Lower frequency routine surveillance endomyocardial biopsies after heart transplantation.
Ludwig T WeckbachUlrich MaurerRene SchrammBruno C HuberKorbinian LackermairMax WeissBruno MeiserChristian HaglSteffen MassbergSandra EifertUlrich GrabmaierPublished in: PloS one (2017)
In heart transplantation (HTx) patients, routine surveillance endomyocardial biopsies (rsEMB) are recommended for the detection of early cardiac allograft rejection. However, there is no consensus on the optimal frequency of rsEMB. Frequent rsEMB have shown a low diagnostic yield in the new era of potent immunosuppressive regimen. Efficacy and safety of lower frequency rsEMB have not been investigated so far. In this retrospective, single centre, observational study we evaluated 282 patients transplanted between 2004 and 2014. 218 of these patients were investigated by rsEMB and symptom-triggered EMB (stEMB). We evaluated EMB results, complications, risk factors for rejection, survival 1 and 5 years as well as incidence of cardiac allograft vasculopathy (CAV) 3 years after HTx. A mean of 7.1 ± 2.5 rsEMB were conducted per patient within the first year after HTx identifying 7 patients with asymptomatic and 9 patients with symptomatic acute rejection requiring glucocorticoide pulse therapy. Despite this relatively low frequency of rsEMB, only 6 unscheduled stEMB were required in the first year after HTx leading to 2 additional treatments. In 6 deaths among all 282 patients (2.1%), acute rejection could not be ruled out as a potential underlying cause. Overall survival at 1 year was 78.7% and 5-year survival was 74%. Incidence of CAV was 17% at 3-year follow-up. Morbidity and mortality of lower frequency rsEMB are comparable with data from the International Society for Heart and Lung Transplantation (ISHLT) registry. Consensus is needed on the optimal frequency of EMB.
Keyphrases
- end stage renal disease
- newly diagnosed
- ejection fraction
- prognostic factors
- heart failure
- risk factors
- left ventricular
- patient reported outcomes
- risk assessment
- stem cells
- mass spectrometry
- bone marrow
- blood pressure
- atrial fibrillation
- extracorporeal membrane oxygenation
- big data
- patient reported
- cross sectional
- case report
- hepatitis b virus
- anti inflammatory
- respiratory failure
- cell therapy
- loop mediated isothermal amplification
- ultrasound guided
- smoking cessation
- aortic dissection
- kidney transplantation
- high speed